Beneficial effects of ceftriaxone against pentylenetetrazole-evoked convulsions
- PMID: 18703755
- DOI: 10.3181/0803-RM-83
Beneficial effects of ceftriaxone against pentylenetetrazole-evoked convulsions
Abstract
Although considered to be generally safe, a number of beta-lactam antibiotics have been associated with epileptic seizures in humans. Furthermore, some beta-lactam antibiotics, including ceftriaxone, are used to evoke convulsions under experimental conditions. Recently it was demonstrated that ceftriaxone increased expression of the glutamate transporter (GLT1) and its biochemical and functional activity in the brain of rodents. GLT1 regulates extracellular concentrations of glutamate, an excitatory amino acid involved in the pathogenesis of seizures and epilepsy. Because of its rapid transfer of glutamate into neurons and adjacent glial cells, GLT1 diminishes glutamate toxicity. We investigated whether ceftriaxone (200 mg/kg body wt) administered intraperitoneally (ip) for 6 days could modify the convulsant effects of pentylenetetrazole (PTZ, 100 mg/kg ip) in inbred male BALBcAnNCR and C57 black (BL)/6 mice aged 4 and 12 weeks. Ceftriaxone pretreatment provided significant protective effects against PTZ-evoked generalized clonic convulsions (GCCs), generalized clonic-tonic convulsions (GCTCs), and convulsion-induced mortality during a period of 30 mins after PTZ administration. The incidence of GCCs, GCTCs, and death was statistically significantly lower for BALBcAnNCR mice of both ages, particularly younger mice. The latency time for each of the three parameters was significantly greater, with the exception of GCCs in adult mice. Protective effects of ceftriaxone were also noticed in adult C57BL/6 mice but not in prepubertal C57BL/6 mice. This is the first demonstration of anticonvulsant effects of ceftriaxone or any other beta-lactam antibiotic, which are not uniform across the mouse population. Our results provide new insight into the effects of ceftriaxone, which need further investigation.
Similar articles
-
Paradoxical facilitation of pentylenetetrazole-induced convulsion susceptibility in mice lacking neuronal nitric oxide synthase.Neuroscience. 2009 Mar 17;159(2):735-43. doi: 10.1016/j.neuroscience.2008.12.040. Epub 2009 Jan 1. Neuroscience. 2009. PMID: 19162139
-
Mirtazapine does not affect pentylenetetrazole- and maximal electroconvulsive shock-induced seizures in mice.Epilepsy Behav. 2007 Aug;11(1):1-5. doi: 10.1016/j.yebeh.2007.04.004. Epub 2007 May 22. Epilepsy Behav. 2007. PMID: 17517536
-
Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with beta-lactam antibiotics.Toxicology. 2006 May 1;222(1-2):114-24. doi: 10.1016/j.tox.2006.02.004. Epub 2006 Mar 6. Toxicology. 2006. PMID: 16549226
-
Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression.Nature. 2005 Jan 6;433(7021):73-7. doi: 10.1038/nature03180. Nature. 2005. PMID: 15635412
-
vGLUT2 heterozygous mice show more susceptibility to clonic seizures induced by pentylenetetrazol.Neurochem Int. 2009 Jul-Aug;55(1-3):41-4. doi: 10.1016/j.neuint.2008.12.019. Epub 2009 Jan 8. Neurochem Int. 2009. PMID: 19171171
Cited by
-
Increased glial glutamate transporter EAAT2 expression reduces epileptogenic processes following pilocarpine-induced status epilepticus.Neurobiol Dis. 2012 Aug;47(2):145-54. doi: 10.1016/j.nbd.2012.03.032. Epub 2012 Apr 6. Neurobiol Dis. 2012. PMID: 22513140 Free PMC article.
-
Modulation of astrocyte glutamate transporters decreases seizures in a mouse model of Tuberous Sclerosis Complex.Neurobiol Dis. 2010 Mar;37(3):764-71. doi: 10.1016/j.nbd.2009.12.020. Epub 2010 Jan 4. Neurobiol Dis. 2010. PMID: 20045054 Free PMC article.
-
Ceftriaxone Treatment Affects EAAT2 Expression and Glutamatergic Neurotransmission and Exerts a Weak Anticonvulsant Effect in Young Rats.Int J Mol Sci. 2019 Nov 21;20(23):5852. doi: 10.3390/ijms20235852. Int J Mol Sci. 2019. PMID: 31766528 Free PMC article.
-
Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo.J Med Chem. 2022 Sep 8;65(17):11703-11725. doi: 10.1021/acs.jmedchem.2c00534. Epub 2022 Aug 19. J Med Chem. 2022. PMID: 35984707 Free PMC article.
-
Increased expression of glutamate transporter GLT-1 in peritumoral tissue associated with prolonged survival and decreases in tumor growth in a rat model of experimental malignant glioma.J Neurosurg. 2013 Oct;119(4):878-86. doi: 10.3171/2013.6.JNS122319. Epub 2013 Aug 2. J Neurosurg. 2013. PMID: 23909244 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical